You are here

Article Text

Article menu
Chest clinic
Audit, research and guideline update
Pleurodesis outcome in malignant pleural mesothelioma
Free
  1. Edward Thomas Hamilton Fysh1,2,
  2. Sze Khen Tan1,3,
  3. Catherine Ann Read1,
  4. Felicity Lee1,
  5. Kate McKenzie1,
  6. Nola Olsen4,
  7. Indunil Weerasena1,
  8. Timothy Threlfall5,
  9. Nicholas de Klerk4,
  10. A William Musk1,4,
  11. Y C Gary Lee1,2
  1. 1Respiratory Department, Sir Charles Gairdner Hospital, Perth, Australia
  2. 2Department of Medicine, School of Medicine and Pharmacology, Centre for Asthma, Allergy and Respiratory Research, University of Western Australia, Perth, Australia
  3. 3Department of General Medicine, Khoo Teck Puat Hospital, Singapore, Singapore
  4. 4School of Population Health, University of Western Australia, Perth, Australia
  5. 5Western Australian Cancer Registry, Western Australia Department of Health, Australia
  1. Correspondence to Professor Y C Gary Lee, University Department of Medicine, Sir Charles Gairdner Hospital, Perth, WA 6009, Australia; gary.lee{at}uwa.edu.au

Abstract

Few data exist on the pleurodesis outcome in patients with malignant pleural mesothelioma (MPM). A retrospective review of the Western Australian Mesothelioma Registry over 5 years revealed 390 evaluable patients. Only a subset of patients (42.3%) underwent pleurodesis, surgically (n=78) or by bedside instillation of sclerosants (n=87). Surgical pleurodesis showed no advantages over bedside pleurodesis in efficacy (32% vs 31% failures requiring further drainage, p=0.98), patient survival (p=0.52) or total time spent in hospital from procedure till death (p=0.36). No clinical, biochemical or radiographic parameters tested adequately predict pleurodesis outcome.

  • Mesothelioma
  • Thoracic Surgery
  • Pleural Disease

https://doi.org/10.1136/thoraxjnl-2012-203043

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Supplementary materials

    • Supplementary Data

      This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

      Files in this Data Supplement: